Butterfly Files Motion to Dismiss Claims in FUJIFILM Sonosite Legal Action

Butterfly Network Inc. has filed a motion to dismiss claims and specific patents from a complaint for patent infringement lawsuit filed on March 9, 2022, by FUJIFILM Sonosite Inc. Butterfly believes the lawsuit alleging infringement of U.S. Patent Nos. 7,169,108;...

ARTIS icono ceiling Angiography System Earns FDA Clearance

Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the ARTIS icono ceiling, a ceiling-mounted angiography system designed for a wide range of routine and advanced procedures in interventional radiology (IR) and cardiology. The...

New Fixed X-ray System Brings ‘Personal Assistant’ to Radiology Departments

GE Healthcare released its most advanced fixed X-ray system yet, the next-generation Definium 656 HD. Leading GE Healthcare’s portfolio of fixed X-ray products, this latest generation of the overhead tube suspension (OTS) system delivers consistent, highly automated,...

Exo Acquires Medo AI

Exo (pronounced “echo”), a pioneering health information and medical devices company, has announced that it is acquiring Medo, a Canadian developer of artificial intelligence (AI) technology, to make ultrasound imaging faster and simpler to use. By integrating Medo’s...

Market Report: AI Continues Growth

Staff report

The global AI in medical imaging market is expected to grow at a compound annual growth rate (CAGR) of 45.68% during the forecast period 2022-2027, according to a news report from Globe Newswire that attributes the information to ReportLinker.

The constant increase in the number of diagnostic procedures and the decline in the number of radiologists and an increasing work pressure on radiologists has increased the need for artificial intelligence adoption in the medical imaging space, according to the report.

In the report “AI In Medical Imaging Market – Global Outlook & Forecast 2022-2027” it states that researchers are looking for multiple ways to implement artificial intelligence into medical imaging. The demand for artificial intelligence is constantly increasing in the medical imaging software market. From cardiac events, neurological conditions, fractures, or thoracic complications, artificial intelligence helps physicians to diagnose and provide treatment quickly. Implementing AI in medical imaging has enhanced medical screening, improved precision medicine software, reduced physicians’ load, and more.

There have been many technological advancements in AI-based medical imaging technologies, which have shown their increasing acceptance in high-income countries, according to the report. 

“Some of the improvements include the development of integrated rtiI software, which can directly be integrated into imaging equipment (MRI or CT scanner) which facilitates the automation of medical image analysis. Other advances include smartphone technology integration in AI in medical imaging in which front-line health workers could non-invasively screen for various conditions by leveraging a smartphone,” it states.

AI in medical imaging has drawn the attention of several radiologists worldwide. It gives faster and more accurate results and reduces diagnostic errors at reduced costs compared to traditional medical imaging methods. Thus, radiologists believe that AI in medical imaging may bring an enormous opportunity for its increasing implementation in the upcoming years, according to

In recent years, many large established companies, such as GE Healthcare and Siemens Healthineers, have enabled themselves to grow AI in the medical imaging market by making huge investments for increasing partnerships and acquisitions. Other large health care-related or software companies not previously invested in health care, such as Thermo Fisher Scientific and Paraxel, have started making huge investments in the market.

Siemens Healthineers, General Electric (GE) Company, Koninklijke Philips, and IBM Watson Health are major players in the global AI in the medical imaging market. International players focus on developing innovative products with advanced technologies and expanding their product portfolio to remain competitive. They are continuously investing extensively in R&D to expand their product portfolio.

Manufacturers such as GE Healthcare constantly focus on introducing new products with innovative technology platforms opening the platform (Edison Developer Program) for other companies offering artificial intelligence technologies to scale and deploy their developed applications across GE Healthcare’s customer base.

Many major players are engaged in strategic acquisitions and partnerships that continue to be a competitive strategy for the key players, thus helping them grow inorganically. Innovative product approvals coupled with R&D activities are also helping vendors expand their presence, enhance growth, and sustain their position in the global market. In 2021, more than 30 countries approved AI in medical imaging technologies that are FDA and CE approved, according to the news report.

There is increasing funding and investments by public and private entities, including large companies, which is also one of the major driving factors of AI in the medical imaging market, it adds. 

“For instance, more than 20 start-ups from various regions have received funds to develop AI-based medical imaging technologies,” the report states. says that North America holds a dominant position in artificial intelligence in the medical imaging market. •




Submit a Comment

Your email address will not be published.